The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Of course the other issue is the level of secrecy around what’s actually happening in China. No country quarantines the vast number of citizens that China has for a bout of seasonal flu! 146 million in lockdown. Affecting every aspect of their lives and the economy of the country. Nope that ain’t no ordinary flu! Top virologists are scared of this one...
CCP will want to get the Chinese workforce back into action ASAP. Huge global economic issues coming down the pipeline otherwise. How do they do that? RELIABLE and RAPID testing. Who can help with that? NCYT. Who has already enquired about NCYT’s product according to the last RNS? China.
Let's not forget China is where it's at. The CE-mark gets this to market. CDC test is proving unreliable and besides the US is small fry at the moment compared to China's needs.
From the RNS: Demand for the tests has come from China, the US and the UK, as well as many other countries around the world.
Because I also like to back these things up:
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities
Go to Section D, 4, d
https://twitter.com/sharp_bj/status/1230135921451757569
"The timelines for FDA review and action on a request for consideration for an EUA will depend on the product profile; the existence, if any, of pending applications for the product; the nature of the emergency; and other relevant factors/ Although the length of time required for FDA action will vary, the Agency recognizes that it is likely that, in an emergency situation that is occurring or believed imminent, a request for consideration for an EUA will be acted upon with a matter of hours or days."